November 20, 2012
When Epocrates officially filed its plans for a $75 million IPO in mid-2010, the point of care medical reference company said it had more than 1 million users across the globe. At the time it said about 40 percent of the physicians in the US used its applications. Two years later Epocrates still has about 1 million total users but about 50 percent of US doctors now use its apps. Epocrates' user...
November 15, 2012
Epocrates has finally launched a native iPad version of it's landmark drug information app, up until now a conspicuous and much-discussed omission. The release is part of a larger strategy by CEO Andy Hurd to turn around the struggling company, which posts its second annual loss this year on revenue estimates of about $110 million.
In an October 30 quarterly investor's call, Hurd mentioned data...